79 related articles for article (PubMed ID: 2079097)
1. Assessment of tumor cell kinetics by monoclonal antibody Ki-67.
Yonemura Y; Ohoyama S; Kimura H; Kamata T; Yamaguchi A; Miyazaki I
Eur Surg Res; 1990; 22(6):365-70. PubMed ID: 2079097
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical staining of proliferating cells in endoscopically biopsied tissues of gastric carcinomas with monoclonal antibody Ki-67.
Yonemura Y; Kimura H; Ooyama S; Kamata T; Yamaguchi A; Matsumoto H; Ninomiya I; Miyazaki I
Oncology; 1991; 48(2):162-5. PubMed ID: 1997941
[TBL] [Abstract][Full Text] [Related]
3. Analysis of proliferative activity using anti-proliferating cell nuclear antigen antibody in gastric cancer tissue specimens obtained by endoscopic biopsy.
Yonemura Y; Kimura H; Fushida S; Tugawa K; Nakai Y; Kaji M; Fonseca L; Yamaguchi A; Miyazaki I
Cancer; 1993 Apr; 71(8):2448-53. PubMed ID: 8095851
[TBL] [Abstract][Full Text] [Related]
4. Ki-67 antigen expression in relation to clinicopathological variables and prognosis in gastric cancer.
Kikuyama S; Kubota T; Shimizu K; Miyakita M
Oncol Rep; 1998; 5(4):867-70. PubMed ID: 9625834
[TBL] [Abstract][Full Text] [Related]
5. Ki-67 as a prognostic marker in colorectal cancer but not in gastric cancer.
Oshima CT; Iriya K; Forones NM
Neoplasma; 2005; 52(5):420-4. PubMed ID: 16151588
[TBL] [Abstract][Full Text] [Related]
6. L-Type amino acid transporter 1 (LAT1) expression in lymph node metastasis of gastric carcinoma: Its correlation with size of metastatic lesion and Ki-67 labeling.
Ichinoe M; Yanagisawa N; Mikami T; Hana K; Nakada N; Endou H; Okayasu I; Murakumo Y
Pathol Res Pract; 2015 Jul; 211(7):533-8. PubMed ID: 25908107
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of Ki-67 and argyrophilic nucleolar organizer region staining for lymph node metastasis in gastric cancer.
Kakeji Y; Korenaga D; Tsujitani S; Haraguchi M; Maehara Y; Sugimachi K
Cancer Res; 1991 Jul; 51(13):3503-6. PubMed ID: 2054789
[TBL] [Abstract][Full Text] [Related]
8. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic significance of the expression of mutated p53 protein and the proliferative activity of cancer cells in patients with esophageal squamous cell carcinoma.
Ikeguchi M; Saito H; Katano K; Tsujitani S; Maeta M; Kaibara N
J Am Coll Surg; 1997 Oct; 185(4):398-403. PubMed ID: 9328389
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical study on the prognostic value of the expression of laminin and Ki-67 receptors in advanced gastric cancer].
de Manzoni G; Guglielmi A; Di Leo A; Tomezzoli A; Laterza E; Bonfiglio M; Biolo S; Tedesco P; Borzellino G
G Chir; 1998; 19(8-9):323-8. PubMed ID: 9734182
[TBL] [Abstract][Full Text] [Related]
11. Ki-67 expression in gastric cancer. Results from a prospective study with long-term follow-up.
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2010; 51(4):655-61. PubMed ID: 21103622
[TBL] [Abstract][Full Text] [Related]
12. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
[TBL] [Abstract][Full Text] [Related]
13. Study on Ki-67 immunoreactivity as a prognostic indicator in patients with advanced gastric cancer.
de Manzoni G; Verlato G; Tomezzoli A; Guglielmi A; Pelosi G; Ricci F; Di Leo A; Cordiano C
Jpn J Clin Oncol; 1998 Sep; 28(9):534-7. PubMed ID: 9793024
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic factors influencing postoperative prognosis in patients with small-sized adenocarcinoma of the lung.
Inoue M; Takakuwa T; Minami M; Shiono H; Utsumi T; Kadota Y; Nasu T; Aozasa K; Okumura M
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):830-6. PubMed ID: 18374763
[TBL] [Abstract][Full Text] [Related]
15. [Proliferative activity in gastric cancer with Ki-67 and propidium iodide: analysis by flow cytometry].
Kimura H; Yonemura Y; Ohyama S; Kamata T; Yamaguchi A; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1992 Apr; 93(4):388-92. PubMed ID: 1603045
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical evaluation of Ki-67, PCNA and MCM2 proteins proliferation index (PI) in advanced gastric cancer.
Czyzewska J; Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Bandurski R
Folia Histochem Cytobiol; 2009; 47(2):289-96. PubMed ID: 19995716
[TBL] [Abstract][Full Text] [Related]
17. Relation of proliferative activity to survival in patients with advanced gastric cancer.
Yonemura Y; Kamata T; Ohoyama S; Matumoto H; Kimura H; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I
Anal Cell Pathol; 1991 Mar; 3(2):103-10. PubMed ID: 2025600
[TBL] [Abstract][Full Text] [Related]
18. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers.
Boo YJ; Park SS; Kim JH; Mok YJ; Kim SJ; Kim CS
J Surg Oncol; 2007 Feb; 95(2):110-7. PubMed ID: 17066436
[TBL] [Abstract][Full Text] [Related]
19. Ki-67 labeling index is a more reliable measure of solid tumor proliferative activity than tritiated thymidine labeling.
Deshmukh P; Ramsey L; Garewal HS
Am J Clin Pathol; 1990 Aug; 94(2):192-5. PubMed ID: 2371973
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
